Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The GABAB receptor is a metabotropic, G protein-coupled receptor (GPCR) for gamma-aminobutyric acid (GABA), the main inhibitory neurotransmitter in the central nervous system. It mediates slow and prolonged inhibitory synaptic transmission and is broadly expressed throughout the nervous system. The functional GABAB receptor is an obligate heterodimer composed of two subunits: GABA B1 and GABA B2. Activation leads to neuronal inhibition.
Activation by GABA leads to activation of Gi/o-type proteins, resulting in the opening of inwardly rectifying potassium channels (GIRKs), inhibition of voltage-gated calcium channels, and inhibition of adenylyl cyclase activity. These actions cause hyperpolarization and reduced excitability in neurons.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gamma Aminobutyric Acid Type B Receptor (GABAB receptor).